Joint Functions of Protein Residues and NADP(H) in Oxygen Activation by Flavin-containing Monooxygenase by Orru, Roberto et al.
  
 University of Groningen
Joint Functions of Protein Residues and NADP(H) in Oxygen Activation by Flavin-containing
Monooxygenase
Orru, Roberto; Torres Pazmino, Daniel; Fraaije, Marco W.; Mattevi, Andrea
Published in:
The Journal of Biological Chemistry
DOI:
10.1074/jbc.M110.161372
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2010
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Orru, R., Torres Pazmino, D., Fraaije, M. W., & Mattevi, A. (2010). Joint Functions of Protein Residues and
NADP(H) in Oxygen Activation by Flavin-containing Monooxygenase. The Journal of Biological Chemistry,
285(45), 35021-35028. https://doi.org/10.1074/jbc.M110.161372
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Joint Functions of Protein Residues and NADP(H) in Oxygen
Activation by Flavin-containing Monooxygenase*
Received for publication, July 5, 2010, and in revised form, August 24, 2010 Published, JBC Papers in Press, August 31, 2010, DOI 10.1074/jbc.M110.161372
Roberto Orru‡, Daniel E. Torres Pazmin˜o§, MarcoW. Fraaije§1, and Andrea Mattevi‡2
From the‡Department of Genetics andMicrobiology, University of Pavia, Via Ferrata 1, 27100 Pavia, Italy and the §Laboratory of
Biochemistry, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 4, 9747 AG
Groningen, The Netherlands
The reactivity of flavoenzymes with dioxygen is at the heart of
a number of biochemical reactions with far reaching implications
for cell physiology andpathology. Flavin-containingmonooxygen-
ases are an attractive model system to study flavin-mediated oxy-
genation. In these enzymes, the NADP(H) cofactor is essential for
stabilizing the flavin intermediate, which activates dioxygen and
makes it ready to reactwith the substrate undergoingoxygenation.
Our studies combine site-directed mutagenesis with the usage of
NADP analogues to dissect the specific roles of the cofactors and
surrounding protein matrix. The highlight of this “double-engi-
neering” approach is that subtle alterations in the hydrogen bond-
ing and stereochemical environment can drastically alter the effi-
ciency and outcome of the reactionwith oxygen. This is illustrated
by the seemingly marginal replacement of an Asn to Ser in the
oxygen-reacting site, which inactivates the enzyme by effectively
converting it into an oxidase. These data rationalize the effect of
mutations that cause enzyme deficiency in patients affected by the
fish odor syndrome. A crucial role of NADP in the oxygenation
reaction is to shield the reacting flavin N5 atom by H-bond inter-
actions. A Tyr residue functions as backdoor that stabilizes this
crucial binding conformation of the nicotinamide cofactor. A
general concept emerging fromthis analysis is that the twoalter-
native pathways of flavoprotein-oxygen reactivity (oxidation
versus monooxygenation) are predicted to have very similar
activation barriers. The necessity of fine tuning the hydrogen-
bonding, electrostatics, and accessibility of the flavin will repre-
sent a challenge for the design and development of oxidases and
monoxygenases for biotechnological applications.
Flavin-containing monooxygenases (FMOs)3 form a large
family of enzymes present almost ubiquitously among living
organisms (1, 2, 3). They are involved in diverse biological
processes such as the biosynthesis of various natural prod-
ucts (4) and catabolism of xenobiotics. Humans have five
different isozymes that are coded by different genes and rep-
resent a key enzymatic system in drug metabolism, whose
relevance almost equals that of cytochrome P450s. Among
known FMO substrates, there are metabolites directly or indi-
rectly deriving from food digestion such as trimethylamine,
drugs such as tamoxifen, and toxic molecules such as nicotine.
Mutations in the gene for the isozyme 3 of human FMO
(FMO3), which is most abundant in the liver, are directly
responsible for trimethylaminuria, also known as fish odor syn-
drome (TMAU). This genetic disease causes the accumulation
of trimethylamine so that the body of the patients tend to have
an unpleasant smell (5, 6).
Irrespectively of their biological context, FMOs always
catalyze the same reaction: the oxygenation of a soft nucleo-
phile using molecular oxygen as oxygen source and NADPH
as electron donor (7) (Fig. 1A). At the heart of this very
complex reaction is the stabilization of the flavin-hydroper-
oxide adduct resulting from the reaction of dioxygen with the
two-electron reduced FAD (Fig. 1A). Equally essential is the
role of NADP(H). This cofactor not only acts as the electron
donor that reduces the flavin but it directly takes part also
in formation/stabilization of the flavin-hydroperoxide. This
notion is best illustrated by the fact that using alternative elec-
tron donors (e.g. dithionite) in place of NADPH does not sup-
port catalysis because the reaction of dioxygen with the artifi-
cially reduced flavin generates hydrogen peroxide rather than
the stable flavin-hydroperoxide needed for monooxygenation
(8, 9, 10). In the cellular milieu, FMOs are thought to be mainly
in the flavin-hydroperoxide state, ready to attack a suitable sub-
strate (the so-called “cocked gun”) (11).
The peculiar catalytic role of NADP(H) in oxygenation
makes FMOs a very attractive system to study themore general
problem of oxygen reactivity in flavoenzymes. Because it has
been established that the nicotinamide cofactor remains bound
to enzyme during oxygenation, NADP(H) can be exploited as a
probe to gain insight into the reaction of dioxygen with the
reduced flavin and to interrogate the elements that promote the
stabilization of the crucial flavin-hydroperoxide. This concept
represents the starting point of our study that builds on the
previous analysis of the crystal structure and basic biochemical
properties of the FMO from Methylophaga sp. strain SK1
(mFMO, Fig. 1B) (12). This bacterial enzyme shares many fea-
tures with the human FMO3 including a considerable degree of
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sequence identity (33%), a similar substrate specificity, and the
ability to form a stable flavin-hydroperoxide intermediate (13).
At the same time, mFMO is better suited for detailed structural
and enzymological investigations because it is a soluble protein
(i.e. not membrane-associated). The aim of our study is 2-fold:
(i) to gain insight into the astonishing properties of FMOs that
combine in a single active center two cofactors and a complex
sequence of catalytic steps that lead to the formation of an “acti-
vated-form” of dioxygen (flavin-hydroperoxide, Fig. 1A), and
(ii) to translate this knowledge into a molecular rational for the
effects of mutations found in patients affected by TMAU. For
these purposes, we have probed themFMO catalytic properties
by altering both the active site amino acids by site directed
mutagenesis and the NADP(H) substrate by using analogues of
this cofactor. Such a “double-engineering” strategy has revealed
that very fine details in the stereochemical and hydrogen-bond-
ing environment around the flavin determine the efficiency of
the reaction with dioxygen and the nature of the resulting
products.
EXPERIMENTAL PROCEDURES
Protein Purification and Reagents—All reagents were pur-
chased from Sigma-Aldrich. Mutagenesis, protein expression,
and purification were carried out
using standard protocols as previ-
ously described (13). All the experi-
ments were carried out using the
E158A/E159A mutant. This surface
mutation does not affect the enzy-
matic properties but is essential for
the growth of suitable crystals (13).
Throughout the text, we shall refer
to this protein as the wild type.
Steady-state Kinetics—The steady-
state activity of the mFMO variants
was measured spectrophotometri-
cally by monitoring the decrease of
NADPH in time at 340 nm (340 nm
6.22 mM1 cm1). The reactionmix-
ture (1.0 ml) typically contained 50
mM Tris/HCl pH 8.0, 100 mM NaCl,
5% (v/v) glycerol, 3mM-mercapto-
ethanol, 0–200 M NADPH, 0–2
mM trimethylamine, and 0.2–0.6
M mFMO. Trimethylamine was
chosen because it is the best sub-
strate for mFMO (13) and is com-
monly used for FMO activity evalu-
ation (7). The oxidase activity was
probed in the same conditions except
for the absence of trimethylamine.
The corresponding kuncoupling (Table
1) was measured by monitoring the
consumption of NADPH (spectro-
photometrically) and oxygen (using
an oxygen electrode, Hansatech
Oxygraph). Furthermore, the pro-
duction of hydrogen peroxide was
verified using the well-known amplex red/peroxidase assay
as described (14). Reduced NADP analogues (3-acetylpyri-
dine adenine dinucleotide and thioNADP) were generated
enzymatically using glucose-6-phosphate dehydrogenase or
phosphite dehydrogenase. In a typical experiment, solutions
(150 M) of reduced dinucleotides were produced by over-
night incubation in 50 mM Tris-HCl pH 8.0, 150 M glucose-
6-phosphate or phosphite, and 1 unit of dehydrogenase.
Dinucleotide reduction was monitored spectrophotometri-
cally. Enzymatic activities were then carried out as with
NADPH. For 3-acetylpyridine adenine dinucleotide (APADP),
the commercially available reduced form was used as addi-
tional check (OYC Europe). Lack of a monooxygenase activ-
ity was inferred from the absence of an increased rate of
oxygen or NADPH consumption upon addition of trimeth-
ylamine. When no monooxygenase activity was detected
with trimethylamine, a very sensitive colorimetric assay
using indole (whose monooxygenation product spontane-
ously dimerises to indigo) was used as an additional check for
oxygenation activity. Kinetic parameters were determined
bymeasuring at5 different substrate concentrations and the
observed rates were measured in duplicate or triplicate.
Michaelis-Menten kinetic parameters were obtained by fitting
FIGURE 1.Properties of FMOenzymes. A, overall scheme of the reaction and chemical structure of the crucial
flavin-hydroperoxide intermediate that results from the reactionof dioxygenwith theC4aatomof the reduced
flavin. Stabilization of this intermediate requires the presence of a bound NADP molecule. Therefore,
NADP(H) must have two binding modes; one competent in flavin reduction by hydride transfer and one
competent in intermediate stabilization (13).B, overall three-dimensional structureofmFMObound toNADP.
TheNADP-binding and FAD-binding domains are in blue and cyan, respectively. Nitrogens are in blue, oxygens
in red, phosphorous atoms in brown, flavin carbons in yellow, and NADP carbons in cyan.
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the data using Origin software (version 7.0 for Windows) and
were within 15% standard deviation.
Presteady-state Kinetics—Reductive and oxidative half-reac-
tions of mFMO proteins were analyzed using a stopped-flow
apparatus from Applied Photophysics Ltd. (model SX17MV)
equipped with a diode array detector. Spectral data (300–720
nm) were collected at time intervals of 2.5 ms. The obtained
spectrawere analyzed bymeans of numerical integrationmeth-
ods using Pro-K software (Applied Photophysics Ltd.), yielding
individual observed rate constants and deconvoluted spectra
(Table 1 and Fig. 2). All experiments described below were per-
formed at 25 °C in the same buffer used for steady-state exper-
iments using 8–12 M enzyme (after mixing). Each reaction
condition was measured in triplicate. Rate constants obtained
by fitting were within 20% standard deviation. Anoxic condi-
tions were achieved by flushing the system and solutions with
N2 and removing traces of oxygen upon addition of 10 mM
glucose and a catalytic amount of glucose oxidase. Reduction of
mFMObyNADPHwasmeasured anoxically at various concen-
trations of the reduced nicotinamide coenzyme. The observed
rates increased hyperbolically with increasingNADPHconcen-
tration and could be fitted with Equation 1 using non-linear





For measuring the oxidation of reduced mFMO, the enzyme
was first anoxically reduced outside the stopped-flow apparatus
by adding a slight 1.2-fold excess ofNADPH.Only in the case of
the N78K mutant a 10-fold excess of NADPH was needed to
obtain the reduced enzyme form, due to the relatively poor
NADPH affinity of this mutant. The reduced enzyme was sub-
sequently mixed with oxygenated buffer containing equimolar
amounts of NADP. By varying the oxygen concentration (125,
360, and 595 M), the oxygen dependence of the rates for the
reoxidation events was probed. The affinity for NADP (KD,
NADP) was determined bymeasuring the change in the flavin
absorbance spectrum upon titration of 10 M of each mFMO
variant in 50 mM Tris-HCl, pH 7.5 with 0–500 M NADP in
the same buffer.
Crystallization and Structure Determination—All crystals
were obtained usingmicrobatch technique under 100%paraffin
oil at 4 °C bymixing equal volumes of 8mg protein/ml in 25mM
Tris/HCl, pH 8.0, 250mMNaCl, 1 mMNADP (or analog), and
20% (w/v) PEG4000 in 100 mM Na/HEPES pH 7.5 as described
(13). Data were collected at the European Synchrotron Radia-
tion Facility (Grenoble, France) and processed with the CCP4
package (15). The structures were solved by difference Fourier
methods. Phases were further improved by density 4-fold aver-
aging with DM (16). The programs COOT (17) and Refmac5
(18) were used for model rebuilding and refinement, which
was carried out using strict non-crystallographic symmetry
restraints (Table 2). Figures were generated using PyMOL
(DeLano, 2002 on World Wide Web).
RESULTS
Functional Properties of Wild-type mFMO—To provide a
starting point for our studies, we have first investigated the
enzymatic properties of the wild-type enzyme. Steady-state
kinetic analysis revealed that, similar tomammalian FMOs, tri-
methylamine, and NADPH are efficient substrates (Table 1).
Furthermore, it was found that the enzyme has considerable
NADPH oxidase activity as gathered from the rate of NADPH
depletion in the absence of an organic substrate (kuncoupling 
0.5 s1, Table 1). The ability of mFMO to act as NADPH oxi-
dase was further confirmed by measuring the formation of
hydrogen peroxide, which approximately equaled the amount
of consumed NADPH.
The presteady-state analysis using the stopped-flow tech-
nique showed that mFMO is rapidly and almost fully reduced
by NADPH (kred in Table 1). The reductive-half reaction data
also indicated that the enzyme has a high affinity for the
reduced nicotinamide coenzyme. Titration of the oxidized
mFMO revealed a somewhat lower affinity for NADP (Table
1). The NADPH-reduced protein was employed tomonitor the
oxidative half-reaction of mFMO, which can be best described
by a three-step process (rate constants are listed in Table 1 and
Fig. 2A). At first, the relatively stable flavin-hydroperoxide (or
flavin peroxide) intermediate is rapidly formed (spectrum B in
Fig. 2A) with a typical absorbancemaximum at around 360 nm.
Next, the intermediate is converted to a second species (spec-
trum C), which might represent a conformational change
occurring during re-oxidation and/or protonation of the inter-
mediate (i.e. conversion of flavin peroxide into flavin hydroper-
oxide). A partly similar spectral intermediate has been observed
also in the oxidative half-reaction of the pig-liver FMO (10).
Finally, the enzyme is completely re-oxidized (spectrumD). It is
of note that the actual reaction of the flavin with oxygen (i.e.
formation of the flavin-hydroperoxide; A3 B in Fig. 2A) lin-
early depends on the oxygen concentration as typically found in
TABLE 1
Steady-state and presteady-state kinetic parameters
Steady state Titration, Kd,NADP
Presteady state
Km,TMA Km,NADPH kcat kuncoupling Kd,NADPH kred kox
M M s1 s1 M M s1 M1 s1
WT 7 18.6 3.3 0.5 21 10 18.4 65,000
WTa NDb NDb 0.4 0.2 – – – –
WTc – – – 0.13 – – – –
N78K – 160 – 0.07 250 250 0.1 670
N78S – 3.6 – 0.7 22 10 6.7 5,000
N78D – 85 – 0.19 250 270 1.9 2,200
a Performed using 150 M thioNADPH and monitoring oxygen consumption.
bND, not determined.
c Performed using 150 M APADPH and monitoring oxygen consumption.
Oxygen Reactivity in Flavin-containingMonooxygenases
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flavin-dependent oxidases and monooxygenases (rate constant
kox of 6.5 104 M1 s1, Table 1). By repeating the experiments
with 1 mM trimethylamine, it was found that kox does not
depend on the binding of substrate. This is in contrast with
flavoprotein hydroxylases and P450 monooxygenases but is
fully in line with previous kinetic studies on eukaryotic FMOs
(10). Consistent with this mode of function, the three-dimen-
sional structure of mFMO exhibits a two-domain organization
that defines a large cleft at the domain interface (Fig. 1B). At the
bottom of this cleft, a small pocket is defined by the nicotina-
mide moiety of NADP, the side chain of Asn-78, and the
N5-C4a flavin atoms. This is the site where dioxygen reacts
with the reduced flavin forming the flavin-hydroperoxide,
which remains exposed to the incoming substrate (Fig. 3A).
The N78SMutant—The position of Asn-78 in direct contact
with the C4a atom of the flavin and close to the NADP nico-
tinamide ring. This indicated that this side chain could play a
key role in the reaction with dioxygen (Figs. 1 and 3A). Further-
more, two mutations affecting the corresponding residue in
human FMO3 have been identified in TMAU patients (19, 20,
21). Thus, Asn-78 represented an obvious target for site-di-
rected mutagenesis.
At first, we generated the N78S mutation, which is one of
the mutations known to be the cause of TMAU. It is a rela-
tively conservative amino acid replacement that does not
greatly perturb the bulkiness of the side chain and maintains
a group capable of H-bonding interactions. Nevertheless, we
found that the mutant is inactive against various potential
FMO substrates (trimethylamine, nicotine, methimazole,
and indole). Themutant was further investigated for its reac-
tivity toward NADPH and oxygen. Steady-state kinetics
showed that N78S has oxidase activity with a Km for NADPH
of about 4 M and a rate constant (kuncoupling) of 0.7 s1, which
is very similar to that of the wild-type (Table 1). Stopped-flow
kinetics confirmed that the mutant enzyme readily reacts with
NADPH. It also demonstrated that the enzyme reacts with oxy-
gen albeit less efficiently than the
wild-type (13-fold lower kox, Table
1) and, most importantly, without
any detectable flavin-hydroperox-
ide intermediate (Fig. 2B). The
kinetic data for the re-oxidation
reaction could be best fitted by a
one-step process implying that, if
the flavin-hydroperoxide forms, it
decays rapidly being unable to sus-
tain substrate oxygenation.
The crystallographic analysis
of the protein in complex with
NADP indicated no conforma-
tional changes both in the overall
structure and locally in the active
site (Fig. 3A). In essence, placing
a Ser in place of an Asn in position
78 slightly widens the oxygen site at
the flavin C4a-N5 locus. The only
detectable alteration outlined by the
crystallographic data concerns the
NADP nicotinamide ring, which is poorly defined by the elec-
tron density whereas the ADP-ribosemoiety is clearly visible in
the density map. This feature indicates that the nicotinamide is
partly disordered. The main lesson from the N78S analysis is
that an apparently small alteration in the flavin C4a environ-
ment is sufficient to convert FMO into a relatively efficient
oxidase, explaining why the corresponding N61S in human
FMO3 leads to enzyme deficiency in patients affected by
TMAU (20, 21).
Adding Charges: N78D and N78K—Having analyzed the
effect of a small hydrophilic side chains at position 78, we
further probed this site by introducing charged side chains.
We generated and studied the mutations N78D and N78K,
the latter also being found in TMAU patients (19). Both
mutants turned out to be unable to catalyze trimethylamine
monooxygenation but exhibited drastically different enzymatic
properties.
N78D functions asmoderately efficient oxidase (kuncoupling of
0.19 s1) although it binds NADPH with a 20-fold worse
affinity than the wild-type (Table 1). As for the N78S protein,
the presteady-state kinetics showed that the N78D mutant is
unable to effectively stabilize the flavin-hydroperoxide with the
re-oxidation process occurring in one step without detectable
intermediates (kox of 2200 M1 s1). These functional proper-
ties can be evaluated in light of the crystallographic analysis of
the mutant enzyme bound to NADP. The structure displays a
peculiar feature: the nicotinamide is flipped out and hosted at
the rim of the active site cleft (Fig. 3B). This binding mode is
brought about by a rotation of the nicotinamide ribose, which
does not affect the conformation of the ADP fragment of
NADP. In this position, the cofactor carboxamide is engaged
in aH-bondwith the Asp-78 side chain, which compensates for
the nicotinamide positive charge.As a result, the flavinN5 atom
remains exposed to solvent without the shielding exerted by
NADP as in the wild-type protein (Fig. 3A). Although this
binding mode does not require significant conformational
FIGURE 2. Presteady-state investigation of mFMO. A, spectra of deconvoluted enzyme species observed
during the oxidative half-reaction in the (A) wild-type and (B) N78S proteins. Anerobic enzymes (12–15 M
protein in 50 mM Tris/HCl, pH 8.0, 100 mM NaCl, 5% glycerol, 3 mM -mercaptoethanol) solutions were anaer-
obically reduced with NADPH and subsequently mixed with oxygenated buffer (125 M oxygen). Numerical
integrations (Pro-K software, Applied Photophysics Ltd) yielded a three-step model for wild-type protein in
which the first step reflects the formation of the flavin-hydroperoxide (A3 B 8 s1). The rates for the B3 C
and C3 D are 4 s1 and 0.5 s1, respectively. Their values are independent of oxygen concentrations. The
analogous kinetic data of N78S mutant were best fitted using a single-step model (Table 1).
Oxygen Reactivity in Flavin-containingMonooxygenases
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changes in the active site residues, it is evident that such amod-
ified NADP-binding drastically alters the structure, shape,
and electrostatics of the active site which becomes unable to
promote accumulation of the flavin-hydroperoxide intermedi-
ate. This fully supports the idea that proper NADP binding is
an essential element for the oxygenation reaction.
The N78K mutant exhibited strongly altered catalytic prop-
erties and remarkable structural features. In addition of being
inactive as monooxygenase, the protein is very inefficient in
using NADPH for flavin reduction (Table 1). Equally impaired
is the reaction of the NADPH-reduced enzyme with oxygen,
which occurs without any observable intermediate at a rate (kox
of 670 M1 s1), which is not dissimilar to that of the free flavin
in water. The structural data further emphasize the large per-
turbation caused by the mutation (Fig. 3C). The Lys-78 side
chain points toward the nicotinamide ribose possibly forming a
H-bond with the ribose hydroxyl groups (the N	 atom of
Lys-78 has only weak electron density). The nicotinamide of
NADP is disordered, lacking any significant electron density.
This feature is coupled to a conformational change in the posi-
tion of Tyr-212, which swings into active site pointing toward
to interior of the protein (Fig. 3C). This conformation of Tyr-
212 combinedwith the bulkiness of Lys-78makes the flavinC4a
very crowded and inaccessible, which accounts for the poor
reactivity of this mutant with dioxygen.
The structure of the N78K mutant indicates that Tyr-212
may function as an active-site backdoor. In this scenario, the
conformation found in the N78K protein may well correspond
to that present in the NADP-free enzyme. Thus, the flavin of
the unliganded enzyme is predicted to be partly shielded by
Tyr-212, which, upon nicotinamide cofactor binding, swings
out to position itself above the nicotinamide ring, establishing
favorable stacking interactions with the nicotinamide ring (Fig.
3, A and C). Tyr-212 could also play a role in product release,
displacing NADP. A fascinating observation concerning this
aspect is that the function of Tyr-212 of mFMO is reminiscent
of that played by an active-site tyrosine in human glutathione
reductase, a flavoenzyme that uses NADPH as flavin reductant
and shares the same dinucleotide-binding topology as mFMO
(22).
Modifying the Substrate: NADPH Analogues—Having estab-
lished how critical is the environment around the flavin C4a
atom for the oxygen reaction and for attaining proper NADP
binding, we investigated the effects on catalysis exerted by
alterations in theNADP(H) substrate. To this aim,we employed
two NADP(H) analogues, thioNADP(H) and APADP(H) (Fig.
4A). Both compounds, in the oxidized form, bind tightly to
the protein as inferred by the significant increase (5–7 °C) in
the protein melting temperature measured by ThermoFAD
method as reported (23).
The crystal structure of the complex with thioNADP
revealed that the dinucleotide binds exactly as NADP. The
only noticeable difference concerns the pyridine ring, which is
disordered as gathered from the lack of well-resolved electron
density in all four crystallographically independent subunits
present in the crystal asymmetric unit (Table 2).We found that
thioNADPH is an efficient substrate both in the oxidase and in
the monooxygenase assays (Table 1). Thus, replacement of the
FIGURE 3. Structural data on mFMO mutants. The coloring is as in Fig. 1B
with the carbons of highlighted residues in green. A, structure of N78S muta-
tiondoes not perturb theprotein conformation. Thepicture shows the super-
position of the N78S structure onto that of the wild-type enzyme in the same
orientation as in Fig. 1B. The superposition yields a root-mean-square devia-
tion of 0.16 Å for 443 C atoms (with reference to monomer A of the tet-
rameric enzyme). For the sake of clarity, only the side chain of Ser-78 of the
mutant enzyme is shown (carbons in green). The wild-type structure is col-
ored as in Fig. 1B. The carboxamide group of NADP is oriented with its -NH2
group pointing toward the flavin ring as tomake H-bonds (dashed lines) with
the flavin N5 and O4 atoms. We cannot fully rule out that upon flavin reduc-
tion, the carboxamide flips so that its carbonyl oxygen (rather than theamide)
would point toward the flavin. However, this would cause an unfavorable
short contact between the NADP oxygen and flavin O4 and between the
NADP nitrogen and Arg-413. B, structure of the N78D mutant exhibits an
altered NADP bindingmode with the nicotinamide ring flipped out toward
the surface. This alteration does not involve any large conformational change
in theprotein (root-mean-square deviation of 0.37Å). The coloring is as in Fig.
1Bwith the carbons of Asp-78 in green. C, N78Kmutant displays a disordered
nicotinamide ring (which is therefore not shown) and Tyr-212 oriented
toward the flavin to partly occupy the nicotinamide site. To illustrate the
underlying conformational change, the Tyr-212 side chain and NADP in the
positions as observed in thewild-type enzyme are shown as black thin sticks.
The terminal oxygen of Lys-78 is not fully ordered in the crystal structure. It
might form a H-bond with the NADP ribose.
Oxygen Reactivity in Flavin-containingMonooxygenases
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oxygen atom of the nicotinamide with a bulkier sulfur does not
seem to significantly affect catalysis (Fig. 4A).
APADP(H) turned out to be a more insightful compound to
probe the enzymatic properties. First of all, the reduced form of
this cofactor analog (both commercially obtained or generated
enzymatically) is unable to sustain anymonooxygenase activity.
Instead,we found that it can function as substrate in the oxidase
assay with a rate constant close to that measured with NADPH
(kuncoupling in Table 1) implying that APADPH can reduce the
flavin. The complex ofmFMOwithAPADPproduced crystals
of very good quality resulting in excellent electron densitymaps
that were even better than those obtained with the NADP-
boundproteins. The cofactor analog bindswith theADP-ribose
group in the standard conformation (Fig. 4B). Conversely, the
pyridine ring is positioned at the entrance of the active site cleft
in a bindingmode,which is almost identical to that observed for
NADP in the structure of the N78Dmutant (Figs. 3B and 4, B
and C). This conformation enables Asn-78 to form a H-bond
interaction with the carbonyl group of APADP, leaving the
flavin ring unprotected. Combining these biochemical and
structural data leads to conclusion that the reduced APADPH
must be able to adopt the conformation required for reducing
the flavin (Fig. 1A). However, after flavin reduction, the pyri-
dine moiety moves away from the flavin. A reason for the dif-
fering binding modes between NADP and APADPmight be
that the acetyl group of APADP is unable to donate a H-bond
to the flavin N5 (Figs. 1A, 3A, and 4B). This can be expected
to favor the “flipped out” conformation which allows the
APADP acetyl group toH-bond toAsn-78 (Fig. 4B). As for the
N78D mutant, such a “out” conformation is unable to support
oxygenation because it does not generate the proper environ-
ment for flavin-hydroperoxide stabilization and, possibly,
because itmay hamper the access of the organic substrate to the
flavin (Fig. 4C). On the other hand, the flavin remains accessible
to dioxygen and thereby competent in the oxidase reaction.
DISCUSSION
The specific objective of our study was to investigate the
reaction of FMOwith dioxygenusing site-directedmutagenesis
and NADP(H) analogues as dissecting tools. The general aim
was to improve our knowledge of themolecular basis of TMAU
and to advance our current understanding of the oxygen reac-
tivity in flavoenzymes. Along these lines, we can draw several
conclusions.
The analysis of the Asn-78 mutants indicates that at least
some of the TMAU-causing mutations target the Achilles heel
of the enzyme: the intrinsic “fragility” of the crucial flavin-hy-
droperoxide intermediate, which, if not appropriately stabi-
lized, causes the conversion of the enzyme into an oxidase.
In this scenario, the fact that the devil is in the detail is best
illustrated by theN78S variant (Figs. 2A and 3A). Thismutation
does not affect the steric hindrance and hydrophilic nature of
the side chain and does not cause any detectable change in the
active site conformation. Nevertheless, it fully inactivates the
enzyme. Evidently, the fine details in the environment of
theC4a atom (Fig. 1A) canmake a tremendous difference in the
flavin reactivity. In this case, it appears that a Ser side chain in
position 78 is unable to provide the precisely positioned
H-bond partner required to stabilize the flavin-hydroperoxide,
whose terminal oxygen can accept and donate H-bonds (Figs.
1A and 3A). Therefore, the intermediate does not form at all or,
more likely, it decays too rapidly to sustain monooxygenation
(Fig. 2B). As a result, the mutant enzyme retains (albeit less
FIGURE 4. Binding of NADP analogues to mFMO. A, chemical formulas of
the two compounds using for this study (APADP on the left and thioNADP
on the right). B, structure of the complex with APADP in approximately the
same orientation and coloring scheme as in Fig. 1B. The carbons of APADP
are in green. H-bonds are shown as dashed lines. C, comparison between the
binding of NADP and APADP using a composite picture that shows the
protein surface of the wild-type protein bound to NADP (carbons in cyan)
and FAD (carbons in yellow). The pyridine ring of APADP is superimposed to
highlight its different position at the rim of the active-site cleft surface. The
NADP andAPADP complexes are very similar (root-mean-squaredeviation
of 0.21 Å for the C atoms).
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efficient) reactivity with oxygen but only to function as oxidase
and not as monooxygenase (Table 1).
The N78D mutant illustrates the role of electrostatics. This
isosteric mutation positions a negative charge close to the N5
with to a 30-fold reduction in the kox (Table 1). As observed for
other flavoenzymes, it is likely that this mutation disfavors the
first step of the oxygen reaction; the one-electron transfer lead-
ing to the formation of flavin semiquinone-superoxide caged
radical pair that subsequently generates the flavin-hydroperox-
ide and/or hydrogen peroxide (24, 25).
Monooxygenation requires that NADP binds in the proper
conformation as outlined by the study of the N78Dmutant and
the experiments with the APADP analog (Figs. 3B and 4B).
The role of NADP is manifold: (i) together with Asn-78, it
creates the niche for oxygen binding in front of the flavin C4a
atom, (ii) its ribose 2
-hydroxyl group provides a potential
H-bonding partner for the flavin-hydroperoxide atoms (13),
and (iii) it forms keyH-bond interactionswith the flavinN5 and
O4 atoms (Fig. 1B). This latter feature should be emphasized
because it can have a crucial role. It is known that protection of
the flavin N5 atom can enormously enhance the stability of the
flavin-hydroperoxide to the point that the reaction of oxygen
with protein-free reduced N5-alkylriboflavin forms a very sta-
ble and biocatalytically useful hydroperoxide derivative (26,
27). Although the N5 atom of the two-electron reduced flavin
has a very high pKa value (around 20) (28), adequate protection
of this atom is probably needed to inhibit rapid proton
exchange with the solvent which may concomitantly trigger
decay of the flavin-hydroperoxide. Likewise, protection of the
N5 may also prevent that this atom directly takes part in the
oxygen reaction for example by acting as hydrogen or proton
donor.
The comparison of the NADP and APADP complexes
(Fig. 4C) provides a glimpse of the likely mode of binding of the
organic substrate. Indeed, as visualized by Fig. 4C, the “out”
position of the APADP pyridine moiety corresponds to the
location expected for an organic substrate (for example indole
or nicotine) to be monooxygenated by the enzyme. The sub-
strate promiscuity of FMOs, which act on a variety of diverse
molecules, seems to inevitably expose these enzymes to the risk
of binding the pyridine ring of the NADP(H) ligand in the cat-
alytically incorrect positions as indicated by the mutagenesis
and NADP-analog studies. In this context, it is remarkable that
the mFMO appears to use a Tyr residue as a backdoor that
sandwiches the nicotinamide in the H-bonding position with
N5 (Fig. 3C).
The more general conclusion from this analysis is that the
two alternative pathways (oxidation versus monooxygenation)
along the oxygen reaction can be predicted to have very similar
energy barriers so that subtle alterations in the balance of inter-
actions around the C4a-N5 atoms of the flavin can drastically
alter the outcome of the reaction of the reduced enzyme with
dioxygen. This will be a crucial aspect to be considered in the
design and development of FMOs and relatedmonooxygenases
for biocatalytic application.
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